Hansoh Pharmaceutical Group Company Limited

SEHK:3692 Stock Report

Market Cap: HK$222.9b

Hansoh Pharmaceutical Group Dividends and Buybacks

Dividend criteria checks 0/6

Hansoh Pharmaceutical Group is a dividend paying company with a current yield of 0.99%.

Key information

1.0%

Dividend yield

-0.02%

Buyback Yield

Total Shareholder Yield1.0%
Future Dividend Yield1.1%
Dividend Growth41.6%
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Payout ratio42%

Recent dividend and buyback updates

Recent updates

Hansoh Pharmaceutical Group Company Limited Just Beat Revenue Estimates By 13%

Aug 22
Hansoh Pharmaceutical Group Company Limited Just Beat Revenue Estimates By 13%

Earnings Not Telling The Story For Hansoh Pharmaceutical Group Company Limited (HKG:3692) After Shares Rise 28%

Jul 29
Earnings Not Telling The Story For Hansoh Pharmaceutical Group Company Limited (HKG:3692) After Shares Rise 28%

A Look At The Intrinsic Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)

Jul 06
A Look At The Intrinsic Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)

We Take A Look At Why Hansoh Pharmaceutical Group Company Limited's (HKG:3692) CEO Compensation Is Well Earned

Jun 13
We Take A Look At Why Hansoh Pharmaceutical Group Company Limited's (HKG:3692) CEO Compensation Is Well Earned

Subdued Growth No Barrier To Hansoh Pharmaceutical Group Company Limited (HKG:3692) With Shares Advancing 31%

Jun 11
Subdued Growth No Barrier To Hansoh Pharmaceutical Group Company Limited (HKG:3692) With Shares Advancing 31%

Is Hansoh Pharmaceutical Group (HKG:3692) A Risky Investment?

May 21
Is Hansoh Pharmaceutical Group (HKG:3692) A Risky Investment?

Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Shares Climb 31% But Its Business Is Yet to Catch Up

Mar 31
Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Shares Climb 31% But Its Business Is Yet to Catch Up

Calculating The Fair Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)

Mar 23
Calculating The Fair Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)

Do Hansoh Pharmaceutical Group's (HKG:3692) Earnings Warrant Your Attention?

Feb 10
Do Hansoh Pharmaceutical Group's (HKG:3692) Earnings Warrant Your Attention?

Hansoh Pharmaceutical Group Company Limited (HKG:3692) Investors Are Less Pessimistic Than Expected

Dec 27
Hansoh Pharmaceutical Group Company Limited (HKG:3692) Investors Are Less Pessimistic Than Expected

Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Intrinsic Value Is Potentially 41% Above Its Share Price

Dec 10
Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Intrinsic Value Is Potentially 41% Above Its Share Price

Hansoh Pharmaceutical Group (HKG:3692) Seems To Use Debt Rather Sparingly

Nov 21
Hansoh Pharmaceutical Group (HKG:3692) Seems To Use Debt Rather Sparingly

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: 3692 is not paying a notable dividend for the Hong Kong market, therefore no need to check if payments are stable.

Growing Dividend: 3692 is not paying a notable dividend for the Hong Kong market, therefore no need to check if payments are increasing.


Dividend Yield vs Market

Hansoh Pharmaceutical Group Dividend Yield vs Market
How does 3692 dividend yield compare to the market?
SegmentDividend Yield
Company (3692)1.0%
Market Bottom 25% (HK)2.5%
Market Top 25% (HK)6.8%
Industry Average (Pharmaceuticals)2.2%
Analyst forecast (3692) (up to 3 years)1.1%

Notable Dividend: 3692's dividend (0.99%) isn’t notable compared to the bottom 25% of dividend payers in the Hong Kong market (2.44%).

High Dividend: 3692's dividend (0.99%) is low compared to the top 25% of dividend payers in the Hong Kong market (6.75%).


Earnings Payout to Shareholders

Earnings Coverage: 3692 is not paying a notable dividend for the Hong Kong market.


Cash Payout to Shareholders

Cash Flow Coverage: 3692 is not paying a notable dividend for the Hong Kong market.


Discover strong dividend paying companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/07 13:48
End of Day Share Price 2025/11/07 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Hansoh Pharmaceutical Group Company Limited is covered by 39 analysts. 27 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Bo LiBofA Global Research
Ziyu HeChina International Capital Corporation Limited
Jin ZhangChina International Capital Corporation Limited